Skip to content

Tapeboard

STOCK

Dermata Therapeutics (DRMA)

Research · charts · filings · insider activity

Facts as of 2026-10-15

Each figure carries its own date. Quotes are delayed. A headline is the latest news, not a confirmed cause. Not investment advice.

Last on the movers tape	2026-10-15: top gainer, most active, unusual volume, trading halt
Price at that capture	$0.9700 (delayed)
Move that day	+53.97%
Volume that day	169.8M
First seen on Tapeboard	2026-10-15
Trading halt	Code LUDP, halted 2026-10-15 14:26 UTC, resumed 2026-10-15 14:31 UTC
Headline	Papulopustular Rosacea Market Report Now Available, Covers 11 Countries Across North America, Europe, and Asia-Pacific, Profiling Galderma, Journey Medical, Dermata Therapeutics, and Dr. Reddy's Laboratories (2026-08-31)
Page kept until	2026-11-14, unless DRMA is back on the movers tape

Why is Dermata Therapeutics stock moving?

Dermata Therapeutics (DRMA) appeared on Tapeboard's movers tape on 2026-10-15 (top gainer, most active, unusual volume, trading halt). At that capture it traded at $0.9700, up 53.97% on the day with 169.8M shares traded. The halt feed recorded a halt that day: Code LUDP, halted 2026-10-15 14:26 UTC, resumed 2026-10-15 14:31 UTC. Headline matched to the name (2026-08-31): "Papulopustular Rosacea Market Report Now Available, Covers 11 Countries Across North America, Europe, and Asia-Pacific, Profiling Galderma, Journey Medical, Dermata Therapeutics, and Dr. Reddy's Laboratories". Live quote, chart and filings are in the terminal.

DRMA live chartTrading halts todayMarket moversMorning edition

Dermata Therapeutics (DRMA) appeared on Tapeboard's movers tape on 2026-10-15 (top gainer, most active, unusual volume, trading halt). Dated facts: price and move at capture, volume, halts, short interest and the headline our feed matched.

• real-time quotes, streaming l1 + l2, time & sales, intraday charts with 134 indicators
• company fundamentals, income, balance sheet, cash flow, peer compare, analyst estimates
• sec edgar filings, 10-k / 10-q / 8-k searchable with ai-generated summaries
• insider transactions, form 4 buys/sells by execs and 10%+ holders, filterable by size + recency
• options flow, unusual activity, open interest, implied vol (paid tier)
• paper trading, l2-accurate fill simulation (terminal tier)

1. start with the overview, open the scanner, click DRMA, or search the top bar. unified page: price, profile, latest headlines.
2. scan filings next, 8-k feed surfaces material events (earnings, m&a, insider changes). ai summary ships the takeaway in one paragraph.
3. check insider activity, a cluster of form 4 buys from executives often precedes outperformance. feed groups by signer.
4. size in the simulator, paper-trade DRMA with l2-walked fills before risking capital. analytics tracks win rate, profit factor, expectancy.

The same ticker inside the platform, with the sidebar, search and live tools:

Find more setups like DRMA across the tape: